Kepner Wayne, Vest Noel, Risner Emma, Cheng Hannah, Hurley Brian, Snyder Hannah, McGovern Mark
Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.
Stanford Center for Dissemination and Implementation, Stanford University School of Medicine, Palo Alto, CA, USA.
Addict Sci Clin Pract. 2025 Sep 1;20(1):69. doi: 10.1186/s13722-025-00600-y.
The opioid epidemic has prompted nationwide efforts to expand access to medications for opioid use disorder (MOUD). Primary care settings have been identified as a critical access point for patients who may benefit from MOUD treatments. Despite implementation efforts, there is limited understanding of how MOUD practice capability in primary care settings evolves over time or what factors influence clinic-level implementation trajectories.
We conducted a longitudinal study of 95 primary care clinics in California from 2019 to 2024. MOUD practice capability was measured using the Integrating Medications for Addiction Treatment in Primary Care (IMAT-PC) index across three timepoints. Using latent class growth analysis, we analyzed implementation growth trajectories and examined their associations with clinic characteristics and MOUD implementation outcomes (e.g., patient reach and provider adoption).
Three distinct implementation trajectory classes emerged: elevated improving (41.0%), moderate improving (47.4%), and low improving (11.6%). All clinics demonstrated improvements in MOUD practice capability over time. Elevated improving clinics primarily consisted of smaller clinics (< 15,000 patients) and achieved significantly higher number of patients receiving MOUD compared to moderate ( = 0.03) and low improving clinics ( = 0.04). Clinics serving medically underserved populations disproportionately represented the low improving class ( < 0.01). Increase in the number of providers prescribing MOUD did not differ significantly across trajectory classes.
Although all clinics increased MOUD capability, we found significant associations between implementation trajectory classes and changes in patients receiving MOUD over time in primary care-based MOUD programs. Implementation supports may be more effective and efficient if selected and delivered based upon clinic contextual factors, particularly in resource-constrained and underserved settings.
阿片类药物流行促使全国范围内努力扩大阿片类药物使用障碍(MOUD)治疗药物的可及性。初级保健机构已被确定为可能从MOUD治疗中受益的患者的关键接入点。尽管已做出实施努力,但对于初级保健机构中MOUD实践能力如何随时间演变,或哪些因素影响诊所层面的实施轨迹,人们了解有限。
我们对加利福尼亚州的95家初级保健诊所进行了一项从2019年至2024年的纵向研究。使用初级保健中成瘾治疗药物整合(IMAT-PC)指数在三个时间点测量MOUD实践能力。通过潜在类别增长分析,我们分析了实施增长轨迹,并研究了它们与诊所特征和MOUD实施结果(如患者覆盖范围和提供者采用情况)的关联。
出现了三种不同的实施轨迹类别:高提升(41.0%)、中度提升(47.4%)和低提升(11.6%)。所有诊所的MOUD实践能力都随时间有所提高。高提升诊所主要由规模较小的诊所(<15000名患者)组成,与中度提升诊所(P = 0.03)和低提升诊所(P = 0.04)相比,接受MOUD治疗的患者数量显著更多。服务于医疗服务不足人群的诊所中低提升类别所占比例过高(P < 0.01)。不同轨迹类别中开具MOUD药物的提供者数量增加没有显著差异。
虽然所有诊所都提高了MOUD能力,但我们发现基于初级保健的MOUD项目中实施轨迹类别与随时间接受MOUD治疗的患者变化之间存在显著关联。如果根据诊所背景因素选择并提供实施支持,可能会更有效率,特别是在资源有限和服务不足的环境中。